UNSPSC 51321603: Lifibrol

This classification denotes an anti-lipidemic agent with the molecular formula C21H26O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6KWX9X0Q5K, chemically known as benzoic acid, 4-(4-(4-(1,1-dimethylethyl)phenyl)-2-hydroxybutoxy)-, (+-)- but generally known as lifibrol, which bears US NIH Compound Identifier 57112. European Medicines Agency schedules Lifibrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08512MIG.

UNSPSC 51321603 Lifibrol, a Commodity code, covers emergency and acute-care medications that state and local governments procure for fire rescue operations, emergency medical services, hospital systems, and health agency programs. State and local buyers under this code source specific life-support pharmaceuticals—epinephrine, labetalol, adenosine, diltiazem, and other injectable medications—in quantities tied to operational demand, with strict expiration-date and shelf-life requirements (typically nine months minimum from delivery or one year from manufacture) and rapid delivery windows. Issuing bodies include municipal fire and rescue departments, state health and human services agencies, cooperative purchasing alliances spanning multiple states and localities, and regional emergency response systems. Recent solicitations show a mix of direct municipal procurement (IFB from individual city purchasing offices) and larger coordinated multistate cooperative purchasing vehicles that aggregate demand across state and local health systems.

The Texas Health and Human Services Commission posted an RFI in April 2026 to explore direct-to-manufacturer prescription programs, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers across participating state and local facilities, including Oregon. The City of Tampa Purchasing Department solicited sealed bids (Bid No. 26-P-00188, due April 8, 2026) for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials—for use by Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount. Activity concentrates in Florida (Tampa) and the upper Midwest (Minnesota/multistate), with emerging state-level market-exploration activity in Texas. Recent procurement cycles show preference for firm, all-inclusive pricing with FOB delivery terms and bundled safety and compliance documentation (SDS sheets, WCAG accessibility standards, FDA certification, cGMP and DSCSA attestation).